Discipline of Chemistry, University of Newcastle, Callaghan, NSW 2308, Australia.
Int J Mol Sci. 2024 Nov 19;25(22):12396. doi: 10.3390/ijms252212396.
Drug leads with a high Fsp index are more likely to possess desirable properties for progression in the drug development pipeline. This paper describes the first detailed NMR analysis of the borylated intermediate 3-deoxy-3-boronodiethanolamine-1,2:5,6-di--isopropylidene-α-d-galactofuranose and of the corresponding free monosaccharide analogue 3-boronic-3-deoxy-d-galactose in the early stage of the concurrent equilibrium processes of mutarotation and borarotation. A discussion of all potential equilibria is also presented alongside a comparison with relevant B-NMR data available from the scientific literature and our own library.
具有高 Fsp 指数的药物先导物更有可能具有在药物开发管道中取得进展的理想特性。本文描述了首例详细的硼化中间物 3-脱氧-3-硼代二乙醇胺-1,2:5,6-二-O-异亚丙基-α-D-半乳糖呋喃糖和相应的游离单糖类似物 3-硼酸-3-脱氧-D-半乳糖在变旋和硼旋同时平衡过程早期的 NMR 分析。还讨论了所有可能的平衡,并与来自科学文献和我们自己的文库的相关 B-NMR 数据进行了比较。